Bird, S. T., Delaney, J. A. C., Brophy, J. M., Etminan, M., Skeldon, S. C., & Hartzema, A. G. (2013). Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: Risk window analyses using between and within patient methodology. BMJ Publishing Group Ltd.
Citación estilo ChicagoBird, Steven T., Joseph A C. Delaney, James M. Brophy, Mahyar Etminan, Sean C. Skeldon, and Abraham G. Hartzema. Tamsulosin Treatment for Benign Prostatic Hyperplasia and Risk of Severe Hypotension in Men Aged 40-85 Years in the United States: Risk Window Analyses Using between and Within Patient Methodology. BMJ Publishing Group Ltd, 2013.
Cita MLABird, Steven T., et al. Tamsulosin Treatment for Benign Prostatic Hyperplasia and Risk of Severe Hypotension in Men Aged 40-85 Years in the United States: Risk Window Analyses Using between and Within Patient Methodology. BMJ Publishing Group Ltd, 2013.